Ovid Therapeutics Inc.

BOLDMEDICINE

Pharmaceutical research and development;

CGI-I-AS

Psychological assessment services; psychological testing; psychiatric testing; Psychiatric services, namely, psychiatric pharmacological evaluation and management services; Psychiatric services, namely, clinical assessment of a patient's global functioning in connection with initiation of therapeutic treatment; Psychiatric and psychological testing services, namely, preparing, administering, and scoring standardized psychological and psychiatric testing in connection with clinical evaluation of drug therapy;

CGI-S-AS

Psychological assessment services; psychological testing; psychiatric testing; Psychiatric services, namely, psychiatric pharmacological evaluation and management services; Psychiatric services, namely, clinical assessment of a patient's global functioning in connection with initiation of therapeutic treatment; Psychiatric and psychological testing services, namely, preparing, administering, and scoring standardized psychological and psychiatric testing in connection with clinical evaluation of drug therapy;

KERTELSO

Pharmaceutical preparations for the treatment of neurological developmental disorders; Pharmaceutical preparations for the treatment of neurological disorders;The wording KERTELSO has no meaning in a foreign language.;

NURYLBO

Pharmaceutical preparations for the treatment of developmental disorders; Pharmaceutical preparations for the treatment of neurological disorders;

NUVEMZI

Pharmaceutical preparations for the treatment of neurological developmental disorders; Pharmaceutical preparations for the treatment of neurological disorders;The wording NUVEMZI has no meaning in a foreign language.;

OVID

In the Statement, line 5, after FOR, rare neurological is inserted.;Pharmaceutical Research and Development of therapies for * rare neurological * diseases of the brain;

OVID THERAPEUTICS

THERAPEUTICS;Pharmaceutical product evaluation for the treatment of rare neurological diseases and disorders; Pharmaceutical products development for the treatment of rare neurological diseases and disorders; Pharmaceutical research and development for the treatment of rare neurological diseases and disorders;

OVID THERAPEUTICS BOLDMEDICINE

The mark consists of the word OVID wherein the I in OVID is a stylized helix comprised of three diagonal curved lines, the word THERAPEUTICS located under OVID wherein THERAPEUTICS is smaller than OVID and is offset to the right under OVID, a horizontal line located under THERAPEUTICS separating OVID and THERAPEUTICS from the word BOLDMEDICINE which is located under the horizontal line, wherein BOLD is highlighted as compared to MEDICINE.;OVID THERAPEUTICS BOLD MEDICINE;Color is not claimed as a feature of the mark.;THERAPEUTICS;Pharmaceutical product evaluation for the treatment of rare neurological diseases and disorders; Pharmaceutical products development for the treatment of rare neurological diseases and disorders; Pharmaceutical research and development for the treatment of rare neurological diseases and disorders;